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Abstract. Several new HLA-B (B8, B51, Bw62)- and 
HLA-C (Cw6, Cw7)-specific genes were isolated either as 
genomic cosmid or cDNA clones to study the diversity 
of HLA antigens. The allele specificities were identified 
by sequence analysis in comparison with published HLA- 
B and -C sequences, by transfection experiments, and 
Southern and northern blot analysis using oligonucleotide 
probes. Comparison of the classical HLA-A, -B, and -C 
sequences reveals that allele-specific substitutions seem 
to be rare events. HLA-B51 codes only for one allele- 
specific residue: arginine at position 81 located on the cd 
helix, pointing toward the antigen binding site. HLA-B8 
contains an acidic substitution in amino acid position 9 
on the first central/3 sheet which might affect antigen bind- 
ing capacity, perhaps in combination with the rare 
replacement a position 67 (F) on the c~l helix. HLA-B8 
shows greatest homology to HLA-Bw42, -Bw41, -B7, and 
-Bw60 antigens, all of which lack the conserved restric- 
tion sites Pst I at position 180 and Sac I at position 131. 
Both sites associated with amino acid replacements seem 
to be genetic markers of an evolutionary split of the HLA-B 
alleles, which is also observed in the leader sequences. 
HLA-Cw7 shows 98% sequence identity to the JY328 
gene. In general, the HLA-C alleles display lower levels 
of variability in the highly polymorphic regions of the c~ 1 
and c~2 domains, and have more distinct patterns of locus- 
specific residues in the transmembrane and cytoplasmic 
domains. Thus we propose a more recent origin for the 
HLA-C locus. 
Introduction 
a polymorphic heavy chain (M r 40 000-45 000), encod- 
ed within the major histocompatibility complex (MHC) 
on the short arm of chromosome 6, and an invariant light 
chain (M r 12 000), beta-2 microglobulin (B2m), encoded 
on chromosome 15 (Goodfellow et al. 1975, Grey et al. 
1973, Coligan et al. 1981). Each heavy chain is composed 
of three extracellular domains (c~1, ~2, ~3) of about 90 
amino acids, a hydrophobic transmembrane segment, and 
a hydrophilic ytoplasmic region. The products encoded 
by three gene loci (HLA-A, -B, and -C) serve as restriction 
elements for virus-specific and allospecific ytotoxic T 
lymphocytes (CTL) and are therefore major determinants 
in directing tissue graft rejection (Zinkernagel and Doher- 
ty 1979). Additional non-H/A-A, -B, and-C  genes of 
unknown function map between the HLA-B and/or around 
the HLA-A locus (Koller et al. 1987). A characteristic 
feature of the classical class I products is their very high 
degree ofpolymorphism, ainly in the c~l and ~2 domain, 
which occurs within a highly organized framework of con- 
served sequences. The c~3 domain and B2m are relatively 
conserved and show amino acid sequence homology to im- 
munoglobulin constant domains (Orr et al. 1979, Peterson 
et al. 1972, Trfigardh et al. 1979, Smithies and Poulik 
1972). The transmembrane and cytoplasmic regions con- 
tain the majority of locus-specific residues and reveal a 
higher degree of intralocus conservation which reflects 
evolutionary ancestry rather than positive selection 
(Gfissow et al. 1987). 
We have isolated additional HLA class I genes and pre- 
sent here the molecular structures of HLA-B8, -B51, 
-Bw62, -Cw6, and -Cw7 in comparison to the HLA genes 
published to date. 
HLA (human leucocyte antigen) molecules are membrane 
glycoproteins found on the surface of nearly all nucleated 
cells which are formed by a noncovalent association of 
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Materials and methods 
Isolation of the HLA-B and HLA-C clones. The HLA-B-specific cd2.6 
(HLA-B27) cosmid (Weiss et al. 1985) and the allelic d3.3 cosmid were 
isolated from a genomic library (cd) constructed from peripheral white 
blood cells of a healthy donor (HLA-type: A2, B27/B51, Cw2/Cw3). 
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Two other HLA-B-specific clones pMF18 and pMF28, and the HLA- 
C-specific clone pMF17 were isolated from a cDNA library (MF) kindly 
provided by A. Hahn, prepared from RNA of a chronic T-cell leukemia 
(HLA-type: A 1/A2, B8/Bw62, Cw3/Cw7). The HLA-C-specific lones 
pMS 1 and pMS24 were identified in a second cDNA library (MS) con- 
structed fiom RNA of thymocytes (HLA-type: A2/A30, BI3, Cw6). 
The libraries were screened by differential hybridization using a full- 
length class I probe derived from a B27 cDNA clone, an HLA-B-specific 
probe derived from the 3' untranslated region, and a 200 bp Pvu II x Sac 
I HLA-C-specific fragment spanning the region of amino acids 246-312, 
part of the c~3 domain, and the transmembrane segment of the HLA-Cw 1 
cDNA (Sz6ts et al. 1986). The probes were labeled by the random primer 
method (Feinberg and Vogelstein 1983) with c~-32p-dATP (3000 
Ci/mmol). 
DNA sequencing. The DNA sequence analysis of M13 subclones was 
carried out by the dideoxy chain termination method (Sanger et al. 1977). 
Southern and northern blot analysis• Southern blot analysis of genomic 
DNA from various HLA haplotypes was done according to standard pro- 
tocols (Southern 1975). A 1350 bp Sac I fragment from the 5' end of 
the HLA-B27 gene (Weiss et al. 1985) was selected for hybridization• 
Slot blot analysis with isolated RNA was performed with the Minifold 
II SRC 072/0 as described by the supplier (Schleicher and Schuell, 
Dassel, FRG). Purification of the oligonucleotides ( ynthesized by Dr. 
R. Mertz, Genzentrum, Munich, FRG) and hybridization was done as 
described (Geliebter et al. 1986) with the modification that the probe 
was labeled with terminal desoxynucleotidyl transferase and e~-32p-dATP 
(Collins and Hunsaker 1985). 
HLA haplorvpe of the cells used for the studies. 
EBV-transformed B-cell lines. AS (A1, B8, Cw7); CoL (A2/A3, 
B18/B51, Cw5); DS (A2/A3, B35/B37, Cw4); FrDa (A?, B27/?, C?); 
Juso (AI/A2, B7/B8, C?); KR (A2, B44, Cw5); LG2 (A2, B27, Cwl); 
LiCa (A3, B7, Cw7/Cw8); ML (A2/A3, B7/B27, Cw2); MWi (A2, 
B18/B35, Cw4/Cw7); Ni (A3/A29, B35/Bw65, Cw4/Cw8); RL 
(A2/A23, B13/B27, Cw3/Cw6); Sweig (A29, B40*, C?); TY (All, 
B35, Cw4); VL (A2/A3, B13/B18, Cw5/Cw6); WDV (A3, B38, C!). 
The T-cell leukemia line MF. (A1/A2, B8/Bw62, Cw3/Cw7). 
The peripheral blood lymphocytes. CD (A2, B27/B51, Cw2/Cw3); CW 
(A24/A28, B44/Bw60, Cw3/Cw5); DB (A2, B44/Bw41, C?); Eb 
(A3/A32, B7/B51, Cwl); EW (A2/A30, B13/Bw62, Cw3/Cw6); GS 
(A2, B49/Bw62, Cw4); JZ (A25/A30, B18/Bw41); KL (A2/A3, 
B7/B35, Cw4); MS (A2/A30, B13, Cw6); PH (A2/A26, Bw62/?, Cw3); 
and in addition K562, a human chronic myelogenous leukemia cell line 
(HLA class I negative) and SW480, a human colorectal denocarcinoma 
cell line (A2, B8/B17, C?). 
Results 
Characterization o f  HLA-B-  and -C-specific sequences. 
HLA-B51 is contained in the cosmid cd3.3 isolated f rom 
the genomic  l ibrary (cd). The restr ict ion map of  the cd 
3.3 c lone and the sequencing strategy are shown in F igure 
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Fig. l. Restriction map of the cosmid cd3.3 and sequencing strategy of the HLA-B5] gene; the cDNA clones pMFl 8 (HLA-Bw62), pMF28 (HLA-B8), 
pMF17 (HLA-Cw7), and pMS1/pMS24 (HLA-Cw6). Restriction sites are shown in relation to the exons (black boxes); the corresponding protein 
domains of a typical HLA-B heavy chain including the 3' untranslated region are denoted by the following abbreviations: L, leader peptide; c~l, 
c~2, a3, extracellular domains; TM, transmembrane region; Cyt, cytoplasmic regions; 3'UT, 3' untranslated region. Both HLA-C-specific clones 
contain a further segment representing the short, third cytoplasmic region (exon 8). The Pst I sites at the 5'and 3' ends of the cDNA clones were 
generated during construction of the library. The arrows indicate the sequencing strategy. The asterisks indicate the restriction site Sau 3A needed 
for sequencing of additional fragments of pMF28. Taq I sites are denoted only for the cDNA clones 
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B-specific gene, this clone was used directly for DNA- 
mediated gene transfer. The analysis of the transfectant 
clones with the monoclonal antibody $4 (Johnson et al. 
1987) demonstrated that cosmid cd3.3 encodes HLA-B51 
(data not shown). 
HLA-B8 is encoded by the pMF28 clone, which 
hybridized with the HLA-B locus-specific probe. Figure 
1 shows the restriction map of pMF28 and the sequencing 
strategy. Neither this clone nor the other cDNA clones 
possess the entire leader peptide and thus could not be used 
directly for transfection experiments to determine the 
HLA specificity. Partial sequence information of exons 
5, 6, and 7 of the HLA-B-specific DNA clone pHLA- 1, 
isolated from the homozygous cell line LKT (HLA-A1/- 
B8; Ploegh et al. 1980), indicated that pMF28 encodes 
HLA-B8. The protein sequence ofpMF28 is also identical 
in the three extracellular domains to that of the published 
B8 antigen cloned from the heterozygous lymphoblastoid 
cell line (LCL) 721 (Parham et al. 1988). 
HLA-Bw62, the second allele of the heterozygous in- 
dividual MF, must be encoded by the second clone, 
pMF18, identified with the HLA-B-specific probe. 
pMF 18 reveals arestriction pattern distinct from the pMF 
28 clone, as shown in Figure 1. To assign the pMF18 
clone to HLA-Bw62, a specific oligonucleotide derived 
from the region of amino acids 42-48 in the o~1 domain 
was synthesized; this sequence was subsequently found 
to be present in the HLA-B13 sequence (Zemmour et al. 
1988). The Bw62/B13 oligomer was used to correlate the 
expression of the HLA-Bw62 antigen with the presence 
ofmRNA shown by the slot blot analysis (Fig. 2). Specific 
bands were found only in those cells having Bw62 and/or 
B13. 
Assignment of the HLA-Cw6 and Cw7 alleles. DNA se- 
quence determination f the clone pMF17, pMS1, and 
pMS24, hybridizing with the HLA-C-specific probe, con- 
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Fig. 2. RNA-slot blot analysis with a 
pMF 18 (HLA-Bw62) oligonucleotide as
the hybridization probe, derived from 
the sequence ofamino acids 42-48 in the 
cd domain: 5' - GT CCG AGG ATG 
GCG CCC CGG -3 '  (20 mer) 
regions found only in HLA-C sequences ( ee Figs. 3 and 
4). Furthermore, they showed the HLA-C-specific amino 
acid pattern in the cd domain (amino acid 45, 66-76). 
pMF 17 differs from the published Cw3 sequence and thus 
should encode the HLA-Cw7 antigen, the second HLA-C 
allele of individual MF. The clones pMS 1 and pMS24 are 
identical and very likely encode HLA-Cw6, since 
individual MS carries HLA-B13 and -Cw6 on both 
chromosomes. The parents of MS were HLA typed to con- 
firm that MS inherited HLA-B13 and -Cw6 from both 
parents. 
HLA class I sequence analysis. The amino acid sequences 
deduced from these HLA class I clones are compared with 
other published HLA antigen sequences (Fig. 4). The se- 
quences of the known nonclassical class I loci JY328 
(Srivastava et al. 1985), pHLA6.0 (Geraghty et al. 1987), 
HLA-E (LG2-C1), and the pseudogene pHLA12.4 
(Malissen et al. 1982) are also included. In addition, the 
defective class I sequence, pLN-11A (Biro et al. 1983), 
was evaluated when locus-specific residues were assign- 
ed, although this sequence is not included in Figure 4. 
LG2-C1 is a full-length cDNA clone isolated from the 
LG2 cDNA library (Sz6ts et al. 1986, Pohla and Weiss 
1986) corresponding tothe RS5 sequence (Srivastava et 
al. 1987) and is identical to HLA-E (Koller et al. 1988) 
and JTW15 (Mizuno et al. 1988) except for one substitu- 
tion in amino acid position 222 (R=AGG instead of 
E=GAG). 
This sequence comparison reveals that HLA-B51 con- 
tains one allele-specific amino acid: arginine, a basic 
residue at position 81 replaces the common nonpolar 
amino acids alanine or leucine of other genes, pointing 
toward the antigen binding site, according to the X-ray 
crystal!ographic structure analysis of the HLA-A2 
molecule (Bjorkman et al. 1987a, b). The histidine present 
at position 171 instead of the highly conserved tyrosine 
is also found in HIA-B14 (-Bw65) and -B18 (Parham et 
al. 1988). This histidine could also affect interactions be- 
tween the MHC molecule and distinct processed antigens, 
for instance with the backbone of a peptide. As a member 
of the Bw4 subgroup, HLA-B51 shows the sequence 
80(T), 82(L), and 83(R), postulated tobe specific for the 
Bw4 epitope (Wan et al. 1986). The monoclonal ntibody 
$4, which recognizes the HLA-B51 antigen, also reacts 
with additional HLA-B alleles (Bw52, B13, B44, B45, 
Bw57). Analysis of these sequences discloses one epitope 
shared by the HLA-B alleles: asparagine at position 77 
together with the Bw4 characteristic residues 80, 82, and 
83, which may account for the antibody specificity. 
The highest overall sequence identity of HLA-B8 was 
found with HLA-Bw42 and -Bw41 (Parharn et al. 1988) 
and HLA-B7, -B40*, and -Bw60. With the exception of 
the HLA-B40* mutant, all these antigens hare identical 
substitutions atamino acids 131 (R) and 180 (E), which 
300 H. Pohla et al.: Polymorphism and evolution of HLA-B and -C alleles 
EXOR I EXO~ 2 
30 60  90 120 150 
~62 . . . . . . . . . . .  ~ C C ~ C C T C  ~ __CC G~GACCTC.GGCCG G C T C C C ~  ~ T T T C T A C ~ C ~ G C C ~ G ~  C~CC_-~_-~__~(3 :CC~'TTC&TCG(~ 
B8 ~ - -G  -&  -'I' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
B51  ATGCGGGTC~C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -~  -G  ~G ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  T 
CW6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . .  -T  . . . . . . . . . . . . . . . . . . . . .  -G  . . . . .  -G  . . . . . . . . . . . . . . .  -A  . . . . . . . . . . . .  -T  . . . . . . .  
C~7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
180  210 240 2" /0  300 
B~62 ~,CGTGGACC~CACCCAGT' I "CGTGAGGTTC G A C A G ~ C C . C C C , ~ ~ G  CCCCC~GCCAT~&C.4~.~GGGG CCGG~GTA~' I 'GGGACC~G~.ACAG~ TCC~A~--~"~C3~&CCGAC.AG 
. . . . . . . . . . . . .  G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  &GA- -A -  - -G  . . . . . .  -G  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  A -C  . . . . . . . . .  T . . . . . . . . . . . . . . .  -4;; . . . . . . . .  
BSI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -C - -A  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  A -C  . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . . . . .  
Cw6 . . . . . . . . . . . . . .  G -  . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . . . . . . .  AGG-  -•  . . . . . . . . . . .  G - - -G-G-  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  AG -A - - - -4ZG-C-GG- - - - - -G- -G  . . . . . .  T -  
O,¢7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -~-  -A~- -CG-C-GG- - - - -G- -G  . . . . .  T- 
EXON 3 
330 31~0 390 420 450 
~62 A~C~CT~CGCGGCTAC'Z~.CAAC C•C,&GCC,~C, GCCG GGTCTCACACCCTCCAG A~GTACGC. .CTGC~C~CC, ,~C C, GGCC, CCTCCTCCGC~T~C•GTCC ~C~L'AC~ACGG~G4tTT 'A~TCGCCCTG 
98 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  • . . . . .  -A  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
B51  -~ . . . . . . .  -CT-G- -T -C  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -TTC.G . . . .  C . . . .  -T  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  • . . . . .  -A  . . . . . . . . . . . . .  • . . . . . . . . . . . . . . .  
C~8 -A  . . . . . . . . .  • . . . . . . . . . . . . . . . . . . . . . . . . . . .  A . . . . . . . . . . . . . . . . .  T . . . . . . .  T . . . . . . .  -C  . . . . . .  -C  . . . . .  • . . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
C~7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  • . . . . . . . . . . . . . . . . . . . . . . . . .  T . . . . . . . . .  C . . . . . .  -C  . . . . . . . . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
480 510 540 570 600 
B~82 )AcG&GGA~CCTGGACCGCC.GCG GACACG~CGGCTCAGATC~CCCAG~GCAAG TGGG~GGCGGCCCGTGAGGCGGAGCAGTGG A~GCCTACCTc~. .~AGGGCCTGTGCGTGGAG T G G C T C C G C ~ G ~ T A ~  
B8 . . . . . . . . . .  -C  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  T . . . . . . .  -@AC . . . . . . . . . . . . . . . .  . , .AC  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
B$1 . . . . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . .  -..,C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . .  
Cw6 . . . . . . . . .  -C  . . . . . . . . . . .  -C  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -AC  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cw7 . . . . . . . . . .  -C  . . . . . . . . . . . . .  C . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . . . .  T . . . . . . . . . . . . . .  C . . . . . . . . . .  CT  . . . . . . . . . . . . . . . . . .  -AC  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Exo~ 8 
" 630  660 690 720 750 
B~62 ~C&LCGCTGCAG(~;CGCGG ACCCCCCAAAG AC&(]~TGTC.ACCCACCACCCCATCTCTGAC C~TG~GGCCACCCTC. I~QTC~e"EGGG~C~EQ Cr~'TACCCTGCC~GATCACACT~%~C ~GC( ;GG~TGGCGAGG~C~3~ACTCAG 
B0 - -C  . . . . . .  G . . . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
B51  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . .  G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
CW6 . . . . . . . . . . . . . . . . . . . .  A -A  . . . . . . . . . . . .  C . . . . . . . . . .  -T - - -G~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cw7 . . . . . . . . . . . . . . . . .  A -  -A  . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G -  . . . . . .  -G - -C - - -  
Exon  5 
780 810 840 870 900 
BW62 GACACCGAC-CTTGTGGAG3CC-~GACCAGCA GGAGA~%GAACCTTCCAG~AGTGGGCAGCT G T G G T G G ~ G A G C A C . A C . ~  TACAC~TC.CCATGTA~TC.AGGGGCTG CC~%GCCCCTCACCCTGAG~T~ AGCCA 
B~ . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G 
BSI . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cw6 . . . . . . . . . . . . . . . . . . . . . . .  G . . . . . . . . . . .  -Cr- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -G  . . . . . . . .  G . . . . .  C . . . . . . . . . . .  AG . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cw7 . . . . . . . . . . . . . . . . . . . . . . .  G . . . . . . . . . .  -G  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -C  . . . . . . . . . . . . . . .  -G  . . . . . .  A - - ( ; - - - - -C  . . . . . . . . . .  •AG . . . . . . . . . . . . . . . .  C . . . . . . . . .  
Exon 8 EX~ 7 
930 060 900 1020 1050 
Bw62 TCTTCCCAGTC~%CCATCCCCATCGTc~-C.C  ATTGTTGCTC.GCCTGGCTGTCCTAGCJLGTT ~TCGC.AGCTGTGGTC~CTACT GTGATGTGTAGG~C.CTCAG GTGG~ A ~ A G G A G G G ~ ~ G T  CC 
B8 . . . . . . . . . . . . . . .  G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G -  
BSI  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cw6 . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . .  G - -T - -C  CTA-C- - - -C -A  . . . . . . . . .  A~3- - -GT  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -G -  . . . . . . . . . . . . . . .  
Cw7 . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . .  C . . . . . . . . . . . . . . . . . . . .  G -TT- -C  CTA-C- - - -C -T  . . . . . . . . . . .  -A -CG- -  A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -G  . . . . . . . . . . . . . .  G -  
Ixon 8/3  " -0T-Rt~I~ 
1080 I i i0  1140 1170 1200 
B8  - - -CG . . . . . . . . . . . . . . . . . .  : . . . . . .  
BSI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  : -T  . . . . . . . . . . . . . .  G . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  : . . . . . .  
CW8 - - -A  . . . . . . . . . . . . . . . . . . . . .  A . . . . . . . .  TC  . . . . .  T . . . . . . . . . . . . . . . . .  C - :  . . . .  T . . . . .  T . . . . . . . . . . . . . . . . . .  A - - - -T  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  T -T  . . . .  
Cw7 - - -A  . . . . . . . . . . . . . . . . . . . . .  A . . . . . . . .  T~- - - -T  . . . . . . . . . . . . . . . .  -C  -: . . . .  T . . . . .  T . . . . . . . . . . . . . . . . . . .  A - - - -T  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  :GT  . . . .  
1230 1260 1290 1320 1350 
Bw62 ATGT~GTCCCT~GCATAATGTG AGC.AGGTGGAGEGA~CJU:CCTTGTGT CCACTGT~CCCCTGTTCCCATGCTGATCT GTGTTTCCTCCCCAGTCATCTTTCTTGTTC C A G ~ G ~ T G T C T C C A T C T C  
B0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -C  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
951  . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  --C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Cw6 . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -CO . . . . . . . .  C . . . . . . . . . . .  C - - - ' -CA- - - -C  . . . . . . .  C . . . . . .  GA . . . . . . . .  C . . . . . . . . .  A . . . .  : . . . . . . . . . . . . . . . . . .  
Cw7 . . . . . . . . . . . .  T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -CC . . . . . . . .  C . . . . . . . . . . .  C - - - -CA- - - -C  . . . . . . .  C . . . . . . .  GA . . . . . . . .  C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
1300 1410 1440 1470 15~O 
Bw62 TG~'CTC~CTTT)A'G:TC,~CTCA(;CTC,~ ACTTC~*~AC'~ACI~JUUUL~JLG~T CTC,~T) JUUTI"GIWITCI~3U~TATI~ ~ T A ~ G Q I " ~ T ~ T ~ I U ~  J~ I "~I"~CI~TI " l '~  
~0 . . . . . . . . . . . .  -C - :  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
B51 -C  G-  -G  . . . . . . . . . . . . . . .  : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  CW6 -C  G T -G  G 
Cw7 . . . . . . . .  A - -C - - -G  . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  A - - - -GT  . . . . . .  C . . . . . . . . . . . . . . .  -G  . . . . . . . . . . . . . . . . . .  AGC . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -A - - -G- - - -G  . . . . . . . . .  
Bw62 ~C~CCTGaGA:  C 
Be . . . . . . . . . . . .  : -CTTCCAG 
B51 . . . . . . . . . . . .  A . . . . . . . .  • 
Cw6 . . . . . . . . . . . .  A . . . . . . . .  An  
Cw7 . . . . . . . . . . . .  A-  
Fig. 3. Nucleotide sequence of HLA-Bw62 in comparison to HLA-B8, -B51, -Cw6 and -Cw7 sequences. Only the sequence of the exons and the 
3' untranslated region is shown. The translation termination codons and the restriction sites, Taq I, Sac I, and Pst I as mentioned in the Results 
and Discussion, are underlined; the polyadenylation signal is boxed 
destroy the Sac I and Pst I restriction sites (see Fig. 3); 
they also all possess an identical replacement at position 
177 (D). Southern blot analysis using a 1.35 kb Sac I frag- 
ment isolated from the 5' end of the HLA-B27 gene (500 
bp 5' of the start codon to amino acid 131; Weiss et al. 
1985) as a hybridization probe, with Sac I-digested 
genomic DNA,  revealed the 2.6 kb band in HLA-BS, 
-B40*, and Bw41 haplotypes and a 3.1 kb Sac I fragment 
in HLA-B7 and -Bw60 haplotypes which in addition lack 
a Sac I site at the end of exon 5 (Fig. 5). The latter two 
HLA-B alleles furthermore possess an identical substitu- 
tion at position 178 (K). All HLA-B alleles coding for Ser 
at position 131 show the 1.35 kb band, identical to that 
of the probe (see lane LG2, for example). A weakly 
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hybridizing band of 3.1 kb is also present in the WDV 
DNA. Since a 1.35 kb Sac I fragment gives a strong 
hybridization signal, this most likely represents B38, 
while the former fragment must be derived from another 
class I sequence in the WDV genome. In the case of Pst 
I x Eco RI double-digested DNA (data not shown), the 
1.35 kb Sac I probe detects a strongly hybridizing 1.9 kb 
Pst I fragment specific for the HLA-B7, -B8, -Bw41, and 
-Bw60 haplotypes lacking the Pst I site at the end of exon 
3 instead of a 1.65 kb Pst I fragment, which is present 
if glutamine replaces glutamic acid at position 180. 
HLA-B8 contains an aspartic acid on the first/3 strand of 
the cel domain at position 9, which has been defined as 
a potential ligand for an antigenic peptide. Interestingly, 
this rare acidic substitution is located on the same side 
of the groove as the highly polymorphic residue 67 (HLA- 
B8: F) and might join in antigen binding. At the nucleotide 
level, position 9 is associated with an additional Taq I 
restriction site (see Figs. 1 and 3). 
HLA-Bw62 is characterized by a high degree of 
similarity in the first domain with the HLA-B 13 sequence. 
The major differences lie in the cluster of amino acids 
77-83 encompassing the Bw6 epitope. HLA-Bw62, in the 
first half of the a l  domain, is identical to the sequence 
of the HLA-B51 and the HLA-Bw58 molecules. In this 
case, the antigens hare serological crossreactivity. The 
sequence comparison also shows that the HLA-Bw62 an- 
tigen has sequence identity with HLA-B40*, -Bw60, 
-Bw41, -B13, -B44, and -Bw47 between amino acids 62 
and 76. Zemmour and co-workers (1988) proposed this 
linear sequence to be responsible for the serological 
crossreactivity between HLA-B13 and -Bw47 and as a 
possible epitope for the crossreactivity observed with 
molecules of the HLA-B12- and HLA-B40*-related 
groups. Since the same sequence is also preserved in the 
HLA-Bw62 antigen which does not display any crossreac- 
tivity with the above-mentioned specificities, this region 
alone cannot explain the serological patterns. 
The Cw7 sequence contains one allele-specific residue 
at position 273 (S) and is virtually identical (98%) to the 
JY328 sequence (Srivastava et al. 1985), but differs from 
the other HLA-C alleles (90-93 %) as a result of several 
unique substitutions in the conserved cd domain, 
transmembrane and cytoplasmic regions (amino acids 
194,261,267,305,307,326,339; shown in Fig. 4). The 
high sequence similarity explains the Cw7 reactivity of 
the JY328 transfectants (Duceman et al. 1986). 
Discussion 
To study the diversity of HLA antigens, several new HLA- 
B- and HLA-C-specific genes were isolated and compared 
with previously published sequences. When non- 
HLA-A/-B/-C class I sequences are included in such a 
comparison, only a few locus-specific residues can be 
Fig. 5. Southern blot analysis of Sac I- 
digested genomic DNA isolated from 
donors of various haplotypes (see Mate- 
rials and methods for HLA types). A 
1.35 kb Sac I fragment (500 bp 5' of the 
start codon to amino acid 131 of the 
HLA-B27 gene; Weiss et al. 1985) was 
used as the hybridization probe. The 
genomic DNA of lane Ni shows light 
degradation 
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identified. These include not only the HLA-A-specific 
residues, amino acids 71 (S) and 299 (I), and the HLA-B- 
specific residues, amino acids 239 (R) and 300 (I), but 
also several HLA-C locus-specific residues: 45 (G), 297 
(L), 298 (A), 300 (L), 321 (C), 335 (E), and 338 (I), and 
in addition the eighth exon encoding an alanine residue. 
This sequence comparison also confirms that allele- 
specific substitutions are rare events and probably the 
result of point mutations. Half of the amino acid 
replacements are localized within a framework of con- 
served sequences and not in the polymorphic regions. 
Thus, individual alleles are characterized by a cluster of 
amino acid substitutions, and a unique constellation of 
polymorphic residues affects the recognition of antibodies 
and the T-cell receptor. 
As was pointed out previously for the HLA-A and 
HLA-B molecules, polymorphic amino acids display 
locus-specific distributions (Parham et al. 1988). Figure 
6 analyzes the variability of HLA-C molecules, as reveal- 
ed for eight known HLA-C sequences, including Cw2.2 
(Parham et al. 1988), JY328 (Srivastava et al. 1985), and 
Cx52 (Takata et al. 1988). Although the number of se- 
quences is still limited, this analysis reveals that only two 
positions (amino acids 9, 116) for HLA-C exhibit more 
than three different amino acids. Thus, the HLA-C alleles 
are characterized by a somewhat lower level of variability 
in the regions of the o~1 and o~2 domain which are highly 
polymorphic in HLA-A and -B. The highly polymorphic 
region at the end of the cd domain in HLA-A and -B is 
rather invariant in the HLA-C alleles. Together with the 
more distinct pattern of locus-specific residues in the 
transmembrane and cytoplasmic domains, one could pro- 
pose a more recent origin for the HLA-C locus. The 
variability seen in o~3 is higher for the HLA-C locus than 
for the HLA-A and HLA-B molecules. This is accounted 
for mainly by the HLA-Cw7 and JY328 sequences which 
differ at five positions from the other HLA-C alleles. 
In an attempt o find restriction sites and sequence 
similarities which might reflect evolutionary relationships 
among the HLA-B alleles, we used several single-copy 
probes derived from the HLA-B locus to investigate a large 
number of haplotypes (Weiss et al. 1988). Using gene 
flanking probes, polymorphisms in the gene flanking 
regions which correspond with sequence similarities in the 
coding regions were generally not found. However, some 
patterns might be interpreted in this direction. For 
HLA-Bw62, -B51, and -Bw58 we found identity in the 
transmembrane and cytoplasmic regions even at the 
nucleotide level; only one nucleotide substitution was 
found in the first half of exon 2, and minor differences 
are present in the 3' untranslated region. 
Interestingly, two restriction sites were found, which 
are present in more conserved positions when all class I 
sequences were compared, and which divide the HLA-B 
genes into two groups. The larger group of alleles contains 
the restriction sites Sac I and Pst I as genetic markers for 
serine at position 131 and glutamine at position 180. The 
alleles HLA-BZ -B8, Bw41, -Bw42, and -Bw60 are 
members of the second group. They lack these restriction 
sites and encode an additional identical residue (D) at posi- 
tion 177. One exception is the HLA-B40* antigen which 
was postulated to have lost the epitope encompassing 
amino acids 177 and 180 by gene conversion, a result 
which supports this evolutionary relationship of HLA-B 
alleles. The relationship isalso observed when comparing 
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Fig. 6. Variability at different amino 
acid positions for the three xtracellular 
domains of the eight HLA-C molecules 
including Cw2.2 (Parham et al. 1988), 
JY328 (Srivastava et al. 1985), and 
Cx52 (Takata et al. 1988). Cw2.2 only 
differs from Cw2.1 at position 49/50 
(A/P in place of G/R). The protein 
26o sequences were analyzed as described 
by Wu and Kabat (1970). 
Number of different amino acids at a given position 
Variability =
Frequency of the most common amino acid at that position 
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protein sequences of the mature antigens have been 
published for the other alleles of this group, see Fig. 4). 
Similarly, the leader peptides of the HLA-A and HLA-C 
molecules hare a characteristic amino acid pattern. Sur- 
prisingly, the two recently published HLA-B homologous 
sequences from chimpanzee also contain the same set of 
amino acid substitutions as the uncommon serine at 
position 131, glutamic acid at 177, and glutamine at 180, 
present in the one group of HLA-B alleles (Lawlor et al. 
1988, Mayer et al. 1988). This pattern of similarity leads 
to the conclusion that this divergence in an ancestral -B 
sequence arose before separation of the human and chim- 
panzee species (Klein 1987, Mayer et al. 1988). 
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Note added in proof" Recently two Cw7 subtypes in linkage dis- 
equilibrium with either B7 or B8 have been identified (Hajek-Rosenmayr 
et al. 1988, Meeting Abstract). Therefore, pMF17 should encode the 
Cw7.2 variant, whereas JY328 might correspond tothe Cw7.1 variant. 
